Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Central Nervous System Neoplasms 4Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Prostatic Neoplasms 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Teratoma 1Solitary Fibrous Tumor, Pleural 1Rhabdoid Tumor 1Penile Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Mesothelioma, Malignant 1Liposarcoma 1Leiomyosarcoma 1Inflammatory Breast Neoplasms 1Glioma 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1

Interventions

Vincristine 3Thiotepa 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Cyclophosphamide 2Cisplatin 2Carboplatin 2ribociclib 1merphos 1lonafarnib 1etoposide phosphate 1Topotecan 1Temozolomide 1Stem Cell Transplantation 1Radiotherapy, Conformal 1Radiotherapy 1Psychiatric Rehabilitation 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Neoadjuvant Therapy 1Methotrexate 1Leucovorin 1Irinotecan 1Immunohistochemistry 1Gene Expression Profiling 1Everolimus 13-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Rhabdoid Tumor × Neoadjuvant Therapy × Clear all
NCT01233479 2019-04-01

Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

Pediatric Brain Tumor Consortium

Phase NA Withdrawn
CNS

Central Nervous System Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡